Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Combination of Mitiglinide and Metformin in Patients With Type 2 Diabetes Mellitus

NCT01037842 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01037842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Combination of Mitiglinide and Metformin in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
May 31, 2008
Enrollment
145 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes